Currently Browsing

Our Products

Ranolazine Extended-Release Tablets 500 mg – 60/Bottle

Overview

Reference Brand:
RANEXA®
Therapeutic Class:
Cardiovascular

Specifications

GCN:
26459
Strength:
500 mg
Size:
60
NDC #:
59651000960
TE Code:
AB

Order Information

Case Qty (min order qty):
48
Case Weight (lbs):
8.339

Attributes

Physical Form:
Tablets
Shape:
Tablets
Color:
Orange
Imprint:
"Z"/"65"
Prescribing Info
Product News

July 22, 2026 | Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% ... Read more

Product News

July 21, 2026 | Aurobindo Receives FDA Approval for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 150 mg and 300 mg ... Read more

Product News

July 15, 2026 | Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg ... Read more